# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k060585   
B. Purpose for Submission: New Device   
C. Measurand: Adrenocorticotropic hormone (ATCH)   
D. Type of Test: Quantitative electrochemiluminescence immunoassay   
E. Applicant: ROCHE DIAGNOSTICS CORP.   
F. Proprietary and Established Names: Roche Elecsys-ACTH, ACTH CalSet, ACTH CalCheck, PreciControl ACTH   
G. Regulatory Information: 1. Regulation section: 21CFR $\ S$ -862.1025-Adrenocorticotropic hormone (ACTH) test system. 21 CFR $\ S$ -862.1150-Calibrator. 21 CFR $\ S$ -862.1660-Quality control material (assayed and unassayed). 2. Classification: Class II 3. Product code: CKG - Radioimmunoassay, ACTH JIT- Calibrator, secondary JJX- Single (specified) analyte controls (assayed and unassayed) 4. Panel: Chemistry (75)

# H. Intended Use:

1. Intended use(s): See Indications for use

2. Indication(s) for use: Elecsys ACTH Assay: Immunoassay for the in vitro quantitative determination of adrenocorticotropic hormone (ACTH) in human EDTA plasma. The electrochemiluminescence immunoassay “ECLIA” is intended for use on the Roche Elecsys 1010/2010 and MODULAR ANALYTICS E 170 (Elecsys module) immunoassay analyzers. ACTH measurements are used in the differential diagnosis and treatment of certain disorders of the adrenal glands such as Cushings syndrome, adrenocortical insufficiency, and the ectopic ACTH syndrome.

Elecsys ACTH CalSet is used for calibrating the quantitative Elecsys ACTH assay on the Elecsys immunoassay analyzers.

Elecsys ACTH CalCheck:

For use in the verification of the calibration established by the Elecsys ACTH reagent on Elecsys 1010/2010 and MODULAR E170 immunoassay analyzers.

Elecsys PreciControl ACTH is used for quality control of the Elecsys ACTH immunoassay on the Elecsys immunoassay analyzers.

3. Special conditions for use statement(s): For prescription use   
4. Special instrument requirements: Roche Elecsys 1010/2010 and MODULAR ANALYTICS E 170

# I. Device Description:

The Elecsys ACTH Assay consists of 3 wet reagents that include streptavidincoated microparticles, biotinylated mouse monoclonal anti-ACTH antibody, ruthenium-labeled monoclonal mouse anti-ACTH antibody, buffer, and preservatives. Each kit includes reagents for 100 tests.

# J. Substantial Equivalence Information:

1. Predicate device name(s): Immulite ACTH assay, Elecsys Prolactin II Cal Check, and Elecsys PreciControl Troponin T   
2. Predicate 510(k) number(s): k960066, k053059, and k031990 respectively   
3. Comparison with predicate:

Substantial equivalence – similarities   

<table><tr><td colspan="3" rowspan="1">Immunoassay Comparison</td></tr><tr><td colspan="1" rowspan="1">Feature</td><td colspan="1" rowspan="1">Elecsys ACTH</td><td colspan="1" rowspan="1">Predicate DeviceImmulite ACTH Assay</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">Immunoassay for the in vitroquantitative determination ofadrenocorticotropic hormone(ACTH) in human EDTA plasma.The electrochemiluminescenceimmunoassay "ECLIA" is intendedfor use on the Roche Elecsys1010/2010 and MODULARANALYTICS E 170 (Elecsysmodule) immunoassay analyzers.</td><td colspan="1" rowspan="1">For in vitro diagnostic use with theImmulite 2000 analyzer  for thequantitative measurement ofadrenocorticotropic hormone in EDTA,plasma, as an aid in the assessment ofadrenal insufficiency andhypersecretion.</td></tr><tr><td colspan="1" rowspan="1">Indication forUse</td><td colspan="1" rowspan="1">ACTH measurements are used inthe differential diagnosis andtreatment of certain disorders of theadrenal glands such as Cushingssyndrome, adrenocorticalinsufficiency, and the ectopicACTH syndrome.</td><td colspan="1" rowspan="1">As an aid in the assessment of adrenalinsufficiency and hypersecretion.</td></tr><tr><td colspan="1" rowspan="1">Assay Protocol</td><td colspan="1" rowspan="1">Sandwich assay</td><td colspan="1" rowspan="1">Solid-phase, two site</td></tr><tr><td colspan="1" rowspan="1">DetectionProtocol</td><td colspan="1" rowspan="1">ElectrochemiluminescentImmunoassay</td><td colspan="1" rowspan="1">Chemiluminescent immunometricassay</td></tr><tr><td colspan="1" rowspan="1">Sample Type</td><td colspan="1" rowspan="1">Human plasma treated with K3-EDTA</td><td colspan="1" rowspan="1">Human plasma treated with EDTA</td></tr><tr><td colspan="1" rowspan="1">Calibrator</td><td colspan="1" rowspan="1">ACTH CalSet</td><td colspan="1" rowspan="1">ACTH Adjustors (LACL, LACH)</td></tr></table>

<table><tr><td rowspan=1 colspan=3>CalSet Comparison</td></tr><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Elecsys ACTH CalSet</td><td rowspan=1 colspan=1>Predicate DeviceImmulite ACTH Assay</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Two</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Lyophilized</td><td rowspan=1 colspan=1>Same</td></tr></table>

<table><tr><td rowspan=1 colspan=3>CalCheck Comparison</td></tr><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Elecsys ACTH CalCheck</td><td rowspan=1 colspan=1>Predicate DeviceElecsys Prolactin II CalCheck</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Three</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Lyophilized</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Unopened:Store at 2-8°C up to the printedexpiration date on the bottle labelsReconstituted:15 - 25 °C : 4 hrs</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=3>PreciControl Comparison</td></tr><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Elecsys ACTH PreciControl</td><td rowspan=1 colspan=1>Predicate DeviceElecsys PreciControl Troponin T</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Two</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Lyophilized</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Handling</td><td rowspan=1 colspan=1>Dissolve carefully the contents of onebottle by adding exactly 2.0 mL ofdistilled water and allow to standclosed for 15 minutes to reconstitute.Mix carefully, avoiding the formationof foam.</td><td rowspan=1 colspan=1>Same</td></tr></table>

Substantial equivalence – differences   

<table><tr><td rowspan=1 colspan=3>Immunoassay Comparison</td></tr><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Elecsys ACTH</td><td rowspan=1 colspan=1>Predicate DeviceImmulite ACTH Assay</td></tr><tr><td rowspan=1 colspan=1>CalibrationInterval</td><td rowspan=1 colspan=1>E170/Elecsys 2010:After 1 month (28 days) when usingthe same reagent lot.After 7 days (when using the samereagent kit on the analyzer).Elecsys 1010:With every reagent kit.After 7 days (20-25°C).After 3 days (25-32°C).</td><td rowspan=1 colspan=1>Every four weeks.</td></tr><tr><td rowspan=1 colspan=1>Platform</td><td rowspan=1 colspan=1>Roche Elecsys 1010/2010 andMODULAR ANALYTICS E170(Elecsys module) analyzers.</td><td rowspan=1 colspan=1>Immulite 2000 Analyzer</td></tr><tr><td rowspan=1 colspan=1>CalibrationVerification</td><td rowspan=1 colspan=1>ACTH CalCheck</td><td rowspan=1 colspan=1>None stated in the package insert.</td></tr><tr><td rowspan=1 colspan=1>Controls</td><td rowspan=1 colspan=1>PreciControl ACTH</td><td rowspan=1 colspan=1>LACCM: Bi-level ACTH controlmodule (protein based).</td></tr><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Elecsys ACTH</td><td rowspan=1 colspan=1>Predicate DeviceImmulite ACTH Assay</td></tr><tr><td rowspan=1 colspan=1>Reagent Stability</td><td rowspan=1 colspan=1>Unopened:2-8° - Up to the stated expirationdateOpened:2-8°C - 12 weeksOn the E170 / Elecsys 2010 - 4weeksOn the Elecsys 1010:  4 weeks(stored alternately in the refrigeratorand on the analyzer- ambienttemperature 20-25°C; up to 20 hoursopened in total.)</td><td rowspan=1 colspan=1>ACTH Reagent Wedge:Stable at 2 - 8°C until the expirationdate.</td></tr><tr><td rowspan=1 colspan=1>MeasuringRange</td><td rowspan=1 colspan=1>1 - 2,000 pg/mL</td><td rowspan=1 colspan=1>5 - 1,250 pg/mL</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

CLSI - Evaluation of Precision Performance of Clinical Chemistry Devices; Approved Guideline-Second Edition - EP05-A2

# L. Test Principle:

Test principle

• Sandwich principle. Total duration of assay: 18 minutes. 1st incubation: $5 0 ~ \mu \mathrm { L }$ of sample, a biotinylated monoclonal ACTH-specific antibody, and a monoclonal ACTH-specific antibody labeled with a ruthenium complexa react to form a sandwich complex.

2nd incubation: After addition of streptavidin-coated microparticles, the complex becomes bound to the solid phase via interaction of biotin and streptavidin.   
• The reaction mixture is aspirated into the measuring cell where the microparticles are magnetically captured onto the surface of the electrode. Unbound substances are then removed with ProCell. Application of a voltage to the electrode then induces chemiluminescent emission which is measured by a photomultiplier.   
• Results are determined via a calibration curve which is instrument-specifically generated by 2-point calibration and a master curve provided via the reagent barcode.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility:

Reproducibility was determined using Elecsys reagents, pooled human plasma (HP) and controls (PC) in a modified protocol CLSI EP5-A: 6 times daily for 10 days $( \mathtt { n } = 6 0 )$ ; within-run precision on MODULAR ANALYTICS E170 analyzer, $\mathrm { n } = 2 1$ . The following results were obtained:

<table><tr><td rowspan=1 colspan=3>Elecsys 1010/2010</td><td rowspan=1 colspan=3>Within-runprecision</td><td rowspan=1 colspan=3>Total precision</td></tr><tr><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>Meanpg/mL</td><td rowspan=1 colspan=1>pmol/L</td><td rowspan=1 colspan=1>SDpg/mL</td><td rowspan=1 colspan=1>pmol/L</td><td rowspan=1 colspan=1>CV%</td><td rowspan=1 colspan=1>SDpg/mL</td><td rowspan=1 colspan=1>pmol/L</td><td rowspan=1 colspan=1>CV%</td></tr><tr><td rowspan=1 colspan=1>HP 1</td><td rowspan=1 colspan=1>4.9</td><td rowspan=1 colspan=1>1.08</td><td rowspan=1 colspan=1>0.14</td><td rowspan=1 colspan=1>0.031</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>0.27</td><td rowspan=1 colspan=1>0.059</td><td rowspan=1 colspan=1>5.4</td></tr><tr><td rowspan=1 colspan=1>HP 2</td><td rowspan=1 colspan=1>74.2</td><td rowspan=1 colspan=1>16.3</td><td rowspan=1 colspan=1>1.45</td><td rowspan=1 colspan=1>0.319</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>1.75</td><td rowspan=1 colspan=1>0.385</td><td rowspan=1 colspan=1>2.4</td></tr><tr><td rowspan=1 colspan=1>HP 3</td><td rowspan=1 colspan=1>1390</td><td rowspan=1 colspan=1>306</td><td rowspan=1 colspan=1>29.8</td><td rowspan=1 colspan=1>6.56</td><td rowspan=1 colspan=1>2.1</td><td rowspan=1 colspan=1>36.2</td><td rowspan=1 colspan=1>7.97</td><td rowspan=1 colspan=1>2.6</td></tr><tr><td rowspan=1 colspan=1>PCACTH1</td><td rowspan=1 colspan=1>115</td><td rowspan=1 colspan=1>115</td><td rowspan=1 colspan=1>1.76</td><td rowspan=1 colspan=1>0.388</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>1.96</td><td rowspan=1 colspan=1>2.18</td><td rowspan=1 colspan=1>1.7</td></tr><tr><td rowspan=1 colspan=1>PCACTH2</td><td rowspan=1 colspan=1>970</td><td rowspan=1 colspan=1>214</td><td rowspan=1 colspan=1>15.9</td><td rowspan=1 colspan=1>3.50</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>17.6</td><td rowspan=1 colspan=1>3.88</td><td rowspan=1 colspan=1>1.8</td></tr></table>

<table><tr><td rowspan=1 colspan=11>MODULAR ANALYTICS E170</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=5>Within-run precision</td><td rowspan=1 colspan=5>Total precision</td></tr><tr><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=2>Mean</td><td rowspan=1 colspan=2>SD</td><td rowspan=1 colspan=1>CV</td><td rowspan=1 colspan=2>Mean</td><td rowspan=1 colspan=2>SD</td><td rowspan=1 colspan=1>CV</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>pg/mL</td><td rowspan=1 colspan=1>pmol/L</td><td rowspan=1 colspan=1>pg/mL</td><td rowspan=1 colspan=1>pmol/L</td><td rowspan=1 colspan=1>%</td><td rowspan=1 colspan=1>pg/mL</td><td rowspan=1 colspan=1>pmol/L</td><td rowspan=1 colspan=1>pg/mL</td><td rowspan=1 colspan=1>pmol/L</td><td rowspan=1 colspan=1>%</td></tr><tr><td rowspan=1 colspan=1>HP 1</td><td rowspan=1 colspan=1>4.9</td><td rowspan=1 colspan=1>1.08</td><td rowspan=1 colspan=1>0.13</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>2.7</td><td rowspan=1 colspan=1>4.96</td><td rowspan=1 colspan=1>1.09</td><td rowspan=1 colspan=1>0.266</td><td rowspan=1 colspan=1>0.059</td><td rowspan=1 colspan=1>5.4</td></tr><tr><td rowspan=1 colspan=1>HP 2</td><td rowspan=1 colspan=1>64.3</td><td rowspan=1 colspan=1>14.2</td><td rowspan=1 colspan=1>0.41</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>76.1</td><td rowspan=1 colspan=1>16.8</td><td rowspan=1 colspan=1>2.67</td><td rowspan=1 colspan=1>0.588</td><td rowspan=1 colspan=1>3.5</td></tr><tr><td rowspan=1 colspan=1>HP 3</td><td rowspan=1 colspan=1>1205</td><td rowspan=1 colspan=1>265</td><td rowspan=1 colspan=1>7.83</td><td rowspan=1 colspan=1>1.72</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>1444</td><td rowspan=1 colspan=1>318</td><td rowspan=1 colspan=1>53.6</td><td rowspan=1 colspan=1>11.8</td><td rowspan=1 colspan=1>3.7</td></tr><tr><td rowspan=1 colspan=1>PCACTH1</td><td rowspan=1 colspan=1>111</td><td rowspan=1 colspan=1>24.4</td><td rowspan=1 colspan=1>0.70</td><td rowspan=1 colspan=1>0.15</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>114</td><td rowspan=1 colspan=1>25.1</td><td rowspan=1 colspan=1>2.09</td><td rowspan=1 colspan=1>0.460</td><td rowspan=1 colspan=1>1.8</td></tr><tr><td rowspan=1 colspan=1>PCACTH2</td><td rowspan=1 colspan=1>968</td><td rowspan=1 colspan=1>213</td><td rowspan=1 colspan=1>11.4</td><td rowspan=1 colspan=1>2.51</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>972</td><td rowspan=1 colspan=1>214</td><td rowspan=1 colspan=1>19.1</td><td rowspan=1 colspan=1>4.2</td><td rowspan=1 colspan=1>2.0</td></tr></table>

$b$ . Linearity/assay reportable range:

The reportable range of the assay is $1 . 0 { - } 2 0 0 0 \mathrm { p g / m L }$ (0.220-440 pmol/L). This range is defined by the lower detection limit and the maximum of the master curve. Values below the detection limit are reported $\mathrm { a s } < 1 . 0 \mathrm { p g / m L }$ ( $<$ $0 . 2 2 0 \mathrm { p m o l / L }$ ). Values above the measuring range are reported $\mathrm { a s } > 2 0 0 0$ $\boldsymbol { \mathrm { p g / m L } }$ $\mathrm { ( > 4 4 0  p m o l / L ) }$ .

The sponsor demonstrated linearity of the assay up to $1 7 6 6 . 7 \mathrm { p g / m L }$ c. Traceability, Stability, Expected values (controls, calibrators, or methods): Traceability: This method has been standardized gravimetrically with synthetic ACTH produced at Roche.

The CalSet, CalCheck and the PreciControl products are assayed and compared to reference preparations and target values and ranges are assigned. The values for ACTH are standardized against in-house reference standards (synthetic ACTH in analyte-free human plasma matrix).

Study 1: Accelerated Stability

The Elecsys ACTH calibrators were stored at $3 5 \mathrm { { ^ \circ C } }$ for 3 weeks, the reference material at $4 \mathrm { { } ^ { \circ } C }$ . At the end of three weeks, this on-test material was analyzed in duplicate along with a reference material. The recovery was calculated as a percent of the reference value.

Study 2: Reconstituted Stability at $2 0 – 2 5 ^ { \circ } \mathrm { C }$

The Elecsys ACTH calibrators were reconstituted and stored for 4 hours at 20- $2 5 \mathrm { { ^ \circ C } }$ . The respective reference material was stored at $4 \mathrm { { } ^ { \circ } C }$ . At the end of storage time, the on-test material was analyzed in duplicate along with a reference material. The recovery was calculated as a percent of the reference value.

Study 3: Reconstituted Stability at ${ } _ { - 2 0 } { } ^ { \circ } \mathrm { C }$ :

The Elecsys ACTH calibrators were reconstituted and stored for 12 weeks at - $2 0 \mathrm { { } ^ { \circ } C }$ . The respective reference material was stored at $4 ^ { \circ } \mathrm { C }$ . At the end of storage time, the on-test material was analyzed in duplicate along with a reference material. The recovery was calculated as a percent of the reference value.

The sponsor’s acceptance criterion was recovery of signal $9 0 - 1 1 0 \%$ of the reference value.

ACTH CalCheck and PreciControl ACTH: followed the same study protocols as above. The sponsor’s acceptance criterion was recovery of concentration $8 5 - 1 1 5 \%$ of the reference value.

d. Detection limit: $1 . 0 \ : \mathrm { p g / m L }$ (0.220 pmol/L)

The detection limit represents the lowest measurable analyte level that can be distinguished from zero (limit of the blank). It is calculated as the value lying two standard deviations above that of the lowest standard (master calibrator, standard $1 + 2$ SD, within-run precision, $\mathrm { n } = 2 1$ ).

# e. Analytical specificity:

The Elecsys ACTH two-site immunoassay measures intact ACTH 1-39. When ACTH fragments or peptides were added to a patient’s plasma sample with defined ACTH concentration, no interference was observed with ACTH 1-10, ACTH 11-24, beta-MSH, and beta-Endorphin. Other ACTH fragments (ACTH 1-17, ACTH 1-24, ACTH CLIP 18-39, ACTH 22-39, alpha-MSH 1- $1 3 ) >$ approx. $5 0 0 0 \mathrm { p g / m L }$ can bind to one of the antibodies and thereby negatively interfere with the sandwich formation and lead to lower ACTH values. See table below:

<table><tr><td rowspan=1 colspan=1>Cross-Reactant</td><td rowspan=1 colspan=1>Concentrationof cross-reactant[pg/mL]</td><td rowspan=1 colspan=1>ApparentACTH[pg/mL]</td><td rowspan=1 colspan=1>Change inACTHconcentration[pg/mL]</td><td rowspan=1 colspan=1>% Cross-reactivity</td></tr><tr><td rowspan=1 colspan=1>None (control)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>44.1</td><td rowspan=1 colspan=1>--</td><td rowspan=1 colspan=1>--</td></tr><tr><td rowspan=3 colspan=1>ACTH 1-17</td><td rowspan=1 colspan=1>50000</td><td rowspan=1 colspan=1>10.6</td><td rowspan=1 colspan=1>-33.5</td><td rowspan=1 colspan=1>-0.07</td></tr><tr><td rowspan=1 colspan=1>5000</td><td rowspan=1 colspan=1>36.9</td><td rowspan=1 colspan=1>-7.2</td><td rowspan=1 colspan=1>-0.14</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>42.6</td><td rowspan=1 colspan=1>-1.5</td><td rowspan=1 colspan=1>-0.31</td></tr><tr><td rowspan=3 colspan=1>ACTH 1-24</td><td rowspan=1 colspan=1>50000</td><td rowspan=1 colspan=1>10.2</td><td rowspan=1 colspan=1>-33.8</td><td rowspan=1 colspan=1>-0.07</td></tr><tr><td rowspan=1 colspan=1>5000</td><td rowspan=1 colspan=1>37.9</td><td rowspan=1 colspan=1>-6.2</td><td rowspan=1 colspan=1>-0.12</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>42.5</td><td rowspan=1 colspan=1>-1.6</td><td rowspan=1 colspan=1>-0.32</td></tr><tr><td rowspan=3 colspan=1>ACTH 18-39</td><td rowspan=1 colspan=1>50000</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>-42.1</td><td rowspan=1 colspan=1>-0.08</td></tr><tr><td rowspan=1 colspan=1>5000</td><td rowspan=1 colspan=1>14.9</td><td rowspan=1 colspan=1>-29.2</td><td rowspan=1 colspan=1>-0.58</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>37.0</td><td rowspan=1 colspan=1>-7.0</td><td rowspan=1 colspan=1>1.41</td></tr><tr><td rowspan=3 colspan=1>ACTH 22-39</td><td rowspan=1 colspan=1>50000</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>-44.1</td><td rowspan=1 colspan=1>-0.09</td></tr><tr><td rowspan=1 colspan=1>5000</td><td rowspan=1 colspan=1>6.3</td><td rowspan=1 colspan=1>-37.8</td><td rowspan=1 colspan=1>-0.76</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>29.4</td><td rowspan=1 colspan=1>-14.7</td><td rowspan=1 colspan=1>-2.94</td></tr><tr><td rowspan=3 colspan=1>alpha MSH</td><td rowspan=1 colspan=1>50000</td><td rowspan=1 colspan=1>12.3</td><td rowspan=1 colspan=1>-31.8</td><td rowspan=1 colspan=1>-0.06</td></tr><tr><td rowspan=1 colspan=1>5000</td><td rowspan=1 colspan=1>34.3</td><td rowspan=1 colspan=1>-9.8</td><td rowspan=1 colspan=1>-0.20</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>41.3</td><td rowspan=1 colspan=1>-2.8</td><td rowspan=1 colspan=1>-0.56</td></tr></table>

Pro-opiomelanocortin (POMC - partially purified from an adenoma cell line) showed approximately $1 . 6 \%$ cross-reactivity at $1 5 6 0 \ p \mathrm { m o l / L }$ .

The following pharmaceutical compounds were spiked into plasma samples and tested by the Elecsys ACTH on Elecsys 2010 Immunoassay Analyzer.

Each compound was found to be non-interfering at the concentration listed below.

# Compound

Acetaminophen   
Acetylcysteine   
Acetylsalicylic acid   
Ampicillin   
Ascorbic acid   
Ca- Dobesilate   
Cefoxitin   
Cyclosporine   
Doxycycline   
Heparin   
Ibuprofen   
Levodopa   
Methyldopa   
Metronidazole   
Phenylbutazone   
Rifampicin   
Theophylline

# Concentration

20 mg/L   
30 mg/L   
300 mg/L   
200 mg/L   
30 mg/L   
20 mg/L   
250 mg/L   
1 mg/L   
10 mg/L   
10 U/mL   
50 mg/L   
4 mg/L   
2 mg/L   
10 mg/L   
100 mg/L   
20 mg/L   
10 mg/L

The assay is unaffected by icterus (bilirubin $< 2 5 \ \mathrm { m g / d L } )$ ), hemolysis $\mathrm { ( H b < }$ $0 . 4 \ : \mathrm { g / d L }$ ), lipemia (Intralipid $< 1 5 0 0 ~ \mathrm { m g / d L } )$ ), or biotin $( < 6 0 \mathrm { n g / m L } )$ . Rheumatoid factor above $4 0 0 \ \mathrm { I U / m L }$ may interfere with the assay results. The sponsor’s acceptance criterion was recovery within $\pm 1 5 \%$ of initial value.

Studies evaluating high-dose hook effect demonstrated that samples containing ACTH concentrations up to $1 ^ { * } 1 0 ^ { 6 } \mathrm { p g / m L }$ do not give falsely low results with this assay.

f. Assay cut-off: Not Applicable

2. Comparison studies:

a. Method comparison with predicate device: A comparison of the Elecsys ACTH assay (y) with a commercially available ACTH test (x) using clinical samples gave the following regression statistics (units $\scriptstyle = { \mathrm { p g / m L } }$ ): Number of samples measured: 180

Passing/Bablok $\mathrm { y } { = } 1 . 0 8 \mathrm { x } { + } 1 . 2 3 ~ \tau = 0 . 8 9 8$

Linear regression $\mathrm { y } { = } 0 . 9 0 \mathrm { x } { + } 8 . 1 7 ~ \mathrm { r } = 0 . 9 9 2$

SD $\mathrm { ~ \ i ~ } ( \mathrm { m d } 6 8 ) = 2 . 5 5$

$$
\operatorname { S y } . \mathbf { X } = 1 3 . 8
$$

The sample concentrations were between 5.0 and $9 4 1 ~ \mathrm { p g / m L }$ (1.1 and 207 pmol/L).

b. Matrix comparison:

# Not Applicable

3. Clinical studies:

a. Clinical Sensitivity: Not Applicable

b. Clinical specificity: Not Applicable

c. Other clinical supportive data (when a. and b. are not applicable): Not Applicable

4. Clinical cut-off: Not Applicable

5. Expected values/Reference range: Studies with the Elecsys ACTH assay using plasma samples from 354 apparently healthy adults gave the following results (5th-95th percentile): $7 . 2 – 6 3 . 3 \ \mathrm { p g / m L }$ (1.6-13.9 pmol/L)

N. Proposed Labeling: The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.